Gadobutrol in Renally Impaired Patients: Results of the GRIP Study

Conclusions: No safety concerns with gadobutrol in patients with moderate to severe renal impairment were identified. There were no NSF cases.

Source: Investigative Radiology - December 13, 2016 Category: Radiology Tags: Original Articles Source Type: research